• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢适应决定了自然杀伤细胞在肿瘤微环境中是衰竭还是茁壮成长。

Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment.

机构信息

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.

出版信息

Immunol Rev. 2024 May;323(1):19-39. doi: 10.1111/imr.13316. Epub 2024 Mar 9.

DOI:10.1111/imr.13316
PMID:38459782
Abstract

Natural Killer (NK) cells are a top contender in the development of adoptive cell therapies for cancer due to their diverse antitumor functions and ability to restrict their activation against nonmalignant cells. Despite their success in hematologic malignancies, NK cell-based therapies have been limited in the context of solid tumors. Tumor cells undergo various metabolic adaptations to sustain the immense energy demands that are needed to support their rapid and uncontrolled proliferation. As a result, the tumor microenvironment (TME) is depleted of nutrients needed to fuel immune cell activity and contains several immunosuppressive metabolites that hinder NK cell antitumor functions. Further, we now know that NK cell metabolic status is a main determining factor of their effector functions. Hence, the ability of NK cells to withstand and adapt to these metabolically hostile conditions is imperative for effective and sustained antitumor activity in the TME. With this in mind, we review the consequences of metabolic hostility in the TME on NK cell metabolism and function. We also discuss tumor-like metabolic programs in NK cell induced by STAT3-mediated expansion that adapt NK cells to thrive in the TME. Finally, we examine how other approaches can be applied to enhance NK cell metabolism in tumors.

摘要

自然杀伤 (NK) 细胞因其具有多样化的抗肿瘤功能以及能够限制其对非恶性细胞的激活作用,成为癌症过继细胞疗法发展的热门候选者。尽管在血液恶性肿瘤方面取得了成功,但 NK 细胞为基础的疗法在实体肿瘤方面受到了限制。肿瘤细胞经历各种代谢适应,以维持支持其快速和不受控制增殖所需的巨大能量需求。因此,肿瘤微环境 (TME) 中缺乏为免疫细胞活动提供燃料所需的营养物质,并且含有几种抑制 NK 细胞抗肿瘤功能的免疫抑制代谢物。此外,我们现在知道 NK 细胞的代谢状态是决定其效应功能的主要因素。因此,NK 细胞能够承受和适应这些代谢上恶劣的条件对于在 TME 中进行有效和持续的抗肿瘤活性至关重要。考虑到这一点,我们回顾了 TME 中代谢敌意对 NK 细胞代谢和功能的影响。我们还讨论了 STAT3 介导的扩增诱导的 NK 细胞中的肿瘤样代谢程序,这些程序使 NK 细胞能够在 TME 中茁壮成长。最后,我们研究了如何应用其他方法来增强肿瘤中的 NK 细胞代谢。

相似文献

1
Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment.代谢适应决定了自然杀伤细胞在肿瘤微环境中是衰竭还是茁壮成长。
Immunol Rev. 2024 May;323(1):19-39. doi: 10.1111/imr.13316. Epub 2024 Mar 9.
2
Functional and metabolic targeting of natural killer cells to solid tumors.自然杀伤细胞对实体瘤的功能和代谢靶向。
Cell Oncol (Dordr). 2020 Aug;43(4):577-600. doi: 10.1007/s13402-020-00523-7. Epub 2020 Jun 2.
3
NK Cell Metabolism and Tumor Microenvironment.自然杀伤细胞代谢与肿瘤微环境。
Front Immunol. 2019 Sep 24;10:2278. doi: 10.3389/fimmu.2019.02278. eCollection 2019.
4
Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.靶向 SLC1A5 和 SLC3A2/SLC7A5 作为增强肿瘤微环境中抗肿瘤免疫的潜在策略。
Front Immunol. 2021 Apr 19;12:624324. doi: 10.3389/fimmu.2021.624324. eCollection 2021.
5
Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment.靶向肿瘤微环境中自然杀伤细胞-髓系细胞轴的治疗方法。
Front Immunol. 2021 Apr 19;12:633685. doi: 10.3389/fimmu.2021.633685. eCollection 2021.
6
Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?在肿瘤微环境中释放自然杀伤细胞——下一代免疫疗法?
Front Immunol. 2020 Feb 21;11:275. doi: 10.3389/fimmu.2020.00275. eCollection 2020.
7
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances.NK细胞受体在抗肿瘤及健康组织保护中的作用机制与治疗进展
Immunol Lett. 2024 Dec;270:106932. doi: 10.1016/j.imlet.2024.106932. Epub 2024 Sep 18.
8
NK cells to cure cancer.自然杀伤细胞治疗癌症。
Semin Immunol. 2019 Feb;41:101272. doi: 10.1016/j.smim.2019.03.004. Epub 2019 May 10.
9
Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors.实体瘤中 NK 细胞靶向免疫疗法的挑战和最新进展。
Int J Mol Sci. 2021 Dec 23;23(1):164. doi: 10.3390/ijms23010164.
10
Tailoring Natural Killer cell immunotherapy to the tumour microenvironment.针对肿瘤微环境定制自然杀伤细胞免疫疗法。
Semin Immunol. 2017 Jun;31:30-36. doi: 10.1016/j.smim.2017.09.001. Epub 2017 Sep 19.

引用本文的文献

1
Protein-based Radiopharmaceuticals that target fibroblast activation protein alpha: a review of current progress.靶向成纤维细胞活化蛋白α的基于蛋白质的放射性药物:当前进展综述
EJNMMI Radiopharm Chem. 2025 Jun 21;10(1):32. doi: 10.1186/s41181-025-00356-5.
2
Emerging Role of Extracellular pH in Tumor Microenvironment as a Therapeutic Target for Cancer Immunotherapy.细胞外 pH 值在肿瘤微环境中作为癌症免疫治疗的治疗靶点的新作用。
Cells. 2024 Nov 20;13(22):1924. doi: 10.3390/cells13221924.
3
High-throughput screening for optimizing adoptive T cell therapies.
用于优化过继性T细胞疗法的高通量筛选
Exp Hematol Oncol. 2024 Nov 13;13(1):113. doi: 10.1186/s40164-024-00580-w.
4
DPP7 as a Potential Therapeutic Marker for Colorectal Cancer.二肽基肽酶7作为结直肠癌的潜在治疗标志物
J Cancer. 2024 Aug 19;15(16):5425-5439. doi: 10.7150/jca.93112. eCollection 2024.
5
Recent advances in understanding the immune microenvironment in ovarian cancer.卵巢癌免疫微环境研究进展。
Front Immunol. 2024 Jun 5;15:1412328. doi: 10.3389/fimmu.2024.1412328. eCollection 2024.